Citigroup’s Nanobiotix NBTX Stock Holding History

Citigroup’s Portfolio NBTX Stock Details NBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$31	–	6076
2026 Q1	$31	Buy	+1	New	+$26	﹤0.01%	5677
2025 Q2	–	Sell	-241	Closed	-$853	–	5822
2025 Q1	$853	Hold	241	–	–	﹤0.01%	5373
2024 Q4	$692	Sell	241 -3,182	-93%	-$12.7K	﹤0.01%	5618
2024 Q3	$19.7K	Buy	+3,423	New	+$17.8K	﹤0.01%	5191
2024 Q1	–	Sell	-635	Closed	-$4.62K	–	5782
2023 Q4	$4.62K	Buy	+635	New	+$4.02K	﹤0.01%	5344

Other funds holding NBTX

Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Optiver Holding Amsterdam, Netherlands $371B AUM 64.6% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SHIM

Stone House Investment Management Tunkhannock, Pennsylvania $752M AUM 20.1% 1-Year Est. Return

Citigroup's NBTX Position: Q2 2026 in Review

Citigroup sold out of Nanobiotix (NBTX) in Q2 2026, closing a stake of 1 share — an estimated $31 sold.

Citigroup first reported a position in NBTX in Q4 2023 and held it in 5 quarters. The position peaked at $19.7K in Q3 2024. 11 funds tracked by Wall St. Rank hold NBTX as of Q2 2026.

Citigroup reported no remaining Nanobiotix position as of Q2 2026 after selling out during the quarter.
Citigroup sold 1 Nanobiotix share in Q2 2026, an estimated $31.
Citigroup first reported a position in Nanobiotix in Q4 2023 and held it in 5 quarters.
Citigroup's Nanobiotix position peaked at $19.7K in Q3 2024.
11 funds tracked by Wall St. Rank held Nanobiotix as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.